MRMichael Roggendorf

Michael Roggendorf

*This is an algorithmically generated author record based on publicly available information.

Michael Roggendorf has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immunology of HDV Infection

    by M. Fiedler, M. Roggendorf

    Hepatitis delta virus (HDV) infection may occur as coinfection with hepatitis B virus (HBV) or as superinfection of a chronically HBV-infected patient. A strong antibody response is mounted, which persists for many years; however, it is not able to modulate the course of infection. In most cases the superinfection takes a chronic course. In patients with inactive disease (HDV PCR negative) an oligospecific T-helper cell immune response and a cytotoxic T-cell response were found, which were absent in patients with persistent viremia. The role of the cellular immune response in liver injury during acute infection has not been investigated. Vaccination strategies tested in the woodchuck model induced specific B- and T-cell responses but failed to protect from HDV infection.


  • Definition und Diagnostik der akuten und chronischen Hepatitis B

    by M. Roggendorf, S. Roß

    Akute Hepatitis B Erstmals aufgetretene Leberentzündung durch Infektion mit dem Hepatitis-B-Virus (HBV) und dem biochemischen Nachweis einer Leberzellschädigung. Chronische Hepatitis B Leberentzündung durch Infektion mit dem HBV (Persistenz von HBsAg) und dem biochemischen oder pathohistologischen Nachweis einer Leberzellschädigung über mehr als sechs Monate. Konsens Die virologisch-serologische Diagnostik einer akuten Hepatitis B umfasst den Nachweis von HBsAg, Anti-HBc (gesamt und IgM) und HBeAg und ggf. Anti-HBe. Die Untersuchung von Anti-HBc-IgM und HBV-DNA (qualitativ) sind die Methoden der Wahl zum Nachweis einer akuten HBsAg-negativen Hepatitis B (ca. 5 % aller akuten HBV-Infektionen) (B). Die Diagnostik einer chronischen Hepatitis B erfordert sinnvoll aufeinander abgestimmte Schritte. Diese umfassen den Nachweis von HBsAg und Anti-HBc (gesamt), HBeAg und gegebenenfalls HBV-DNA (quantitativ) (A). Erläuterung Konsens Die Quantifizierung der HBV-DNA ist bei chronischer Hepatitis B nur für die Therapieplanung und die Beurteilung der Infektiosität der Patienten bedeutsam (A). Die Bestimmung der HBV-DNA ist in der Regel für die Diagnose einer akuten Hepatitis B nicht erforderlich, jedoch ratsam bei unklarem oder negativem HBsAg-Befund (A). Erläuterung Konsens Eine Genotypisierung (Genotypen A-H) und eine Analyse auf HBV-Varianten sind nicht erforderlich (A). Erläuterung


  • Health care workers and hepatitis B

    by Michael Roggendorf, Sergei Viazov


  • Open Access

    Coadministration of Gamma Interferon with DNA Vaccine Expressing Woodchuck Hepatitis Virus (WHV) Core Antigen Enhances the Specific Immune Response and Protects against WHV Infection

    by Felix Siegel, Mengji Lu, Michael Roggendorf

    DNA vaccinations are able to induce strong cellular immune responses in mice and confer protection against infectious agents. However, DNA vaccination of large animals appears to be less effective and requires repeated injections of large amounts of plasmid DNA. Enhancement of the efficiency of DNA vaccines may be achieved by coapplication of cytokine-expressing plasmids. Here we investigated, with woodchucks, whether coadministration of an expression plasmid for woodchuck gamma interferon (IFN-γ), pWIFN-γ, can improve DNA vaccination with woodchuck hepatitis virus core antigen (WHcAg). Animals were immunized with pWHcIm (a plasmid expressing WHcAg) alone or with a combination of pWHcIm and pWIFN-γ using a gene gun. Six weeks postimmunization, all animals were challenged with 105genome equivalents of woodchuck hepatitis virus (WHV). The antibody and lymphoproliferative immune responses to WHV proteins were determined after immunization and after challenge. Vaccination with pWHcIm and pWIFN-γ led to a pronounced lymphoproliferative response to WHcAg and protected woodchucks against subsequent virus challenge. Two of three animals vaccinated with pWHcIm alone did not show a detectable lymphoproliferative response to WHcAg. A low-level WHV infection occurred in these woodchucks after challenge, as WHV DNA was detectable in the serum by PCR. None of the pWHcIm-vaccinated animals showed an anti-WHcAg antibody response after DNA vaccination or an anamnestic response after virus challenge. Our results indicate that coadministration of the WIFN-γ gene with pWHcIm enhanced the specific cellular immune response and improved the protective efficacy of WHV-specific DNA vaccines.


  • EXPRESSION AND PURIFICATION OF WOODCHUCK TUMOUR NECROSIS FACTOR ALPHA

    by B Lohrengel, M Lu, D Bauer, M Roggendorf


  • Open Access

    Natural history of hepatitis C.

    by M Roggendorf, H Meisel, S Viazov


  • A suggested extension of the HCV ISDR does not alter our former conclusions on its predictive value for IFN response

    by Kay Rispeter, Mengji Lu, Andree Zibert, Manfred Wiese, Jaqueline Mendes de Oliveira, Michael Roggendorf


  • Immunization of Woodchucks with Plasmids Expressing Woodchuck Hepatitis Virus (WHV) Core Antigen and Surface Antigen Suppresses WHV Infection

    by Mengji Lu, Gero Hilken, Johannes Kruppenbacher, Thekla Kemper, Reinhold Schirmbeck, Joerg Reimann, Michael Roggendorf

    DNA vaccination can induce humoral and cellular immune response to viral antigens and confer protection to virus infection. In woodchucks, we tested the protective efficacy of immune response to woodchuck hepatitis core antigen (WHcAg) and surface antigen (WHsAg) of woodchuck hepatitis virus (WHV) elicited by DNA-based vaccination. Plasmids pWHcIm and pWHsIm containing WHV c- or pre-s2/s genes expressed WHcAg and WHsAg in transient transfection assays. Pilot experiments in mice revealed that a single intramuscular injection of 100 μg of plasmid pWHcIm DNA induced an anti-WHcAg titer over 1:300 that was enhanced by boost injections. However, two injections of 100 μg of pWHcIm did not induce detectable anti-WHcAg in woodchucks. With an increase in the dose to 1 mg of pWHcIm per injection, transient anti-WHcAg response and WHcAg-specific proliferation of peripheral mononuclear blood cells (PMBCs) appeared in woodchucks after repeated immunizations. Four woodchucks vaccinated with pWHcIm were challenged with 104or 105of the WHV 50% infective dose. They remained negative for markers of WHV replication (WHV DNA and WHsAg) in peripheral blood and developed anti-WHs in week 5 after challenge. In contrast, woodchucks not immunized or immunized with the control vector pcDNA3 developed acute WHV infection. Two woodchucks immunized with 1 mg of pWHsIm developed WHsAg-specific proliferative response of PBMCs but no measurable anti-WHsAg response. A rapid anti-WHsAg response developed during week 2 after virus challenge. Neither woodchuck developed any signs of WHV infection. These data indicate that DNA-based vaccination with WHcAg and WHsAg can elicit immunity to WHV infection.


  • T-Cell Response to Woodchuck Hepatitis Virus (WHV) Antigens during Acute Self-Limited WHV Infection and Convalescence and after Viral Challenge

    by Stephan Menne, Jan Maschke, Mengji Lu, Hans Grosse-Wilde, Michael Roggendorf

    The infection of woodchucks with woodchuck hepatitis virus (WHV) provides an experimental model to study early immune responses during hepadnavirus infection that cannot be tested in patients. The T-cell response of experimentally WHV-infected woodchucks to WHsAg, rWHcAg, and WHcAg peptides was monitored by observing 5-bromo-2′-deoxyuridine and [2-3H]adenine incorporation. The first T-cell responses were directed against WHsAg 3 weeks after infection; these were followed by responses to rWHcAg including the immunodominant T-cell epitope of WHcAg (amino acids 97 to 110). Maximal proliferative responses were detected when the animals seroconvered to anti-WHs and anti-WHc (week 6). A decrease in the T-cell response to viral antigens coincided with clearance of viral DNA. Polyclonal rWHcAg-specific T-cell lines were established 6, 12, 18, and 24 weeks postinfection, and their responses to WHcAg peptides were assessed. Five to seven peptides including the immunodominant epitope were recognized throughout the observation period (6 months). At 12 months after infection, T-cell responses to antigens and peptides were not detected. Reactivation of T-cell responses to viral antigens and peptides occurred within 7 days after challenge of animals with WHV. These results demonstrate that a fast and vigorous T-cell response to WHsAg, rWHcAg, and amino acids 97 to 110 of the WHcAg occurs within 3 weeks after WHV infection. The peak of this response was associated with viral clearance and may be crucial for recovery from infection. One year after infection, no proliferation of T cells in response to antigens was observed; however, the WHV-specific T-cell response was reactivated after challenge of woodchucks with WHV and may be responsible for protection against WHV reinfection.